Pioglitazone solid dispersion system prepared by spray drying method: In vitro and in vivo evaluation

PDA Journal of Pharmaceutical Science and Technology

Volumn 67, Issue 1, 2013, Pages 23-34

  Pokharkar, Varsha ^a   Kutwal, Manisha ^a   Mandpe, Leenata ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

In vitro dissolution; In vivo hypoglycaemic activity; Pioglitazone; Solid dispersion; Spray drying

Indexed keywords

GLUCOSE; HYDROXYPROPYLMETHYLCELLULOSE; PIOGLITAZONE; POVIDONE;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG SOLUBILITY; DRUG STABILITY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; SOLID DISPERSION SYSTEM; SPRAY DRYING; SURFACE PROPERTY; X RAY DIFFRACTION; ANIMAL; BIOAVAILABILITY; CHEMISTRY; MEDICINAL CHEMISTRY; SCANNING ELECTRON MICROSCOPY; SOLUBILITY;

ANIMALS; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; MICROSCOPY, ELECTRON, SCANNING; POVIDONE; SOLUBILITY; X-RAY DIFFRACTION;

EID: 84873638988     PISSN: 10797440     EISSN: 19482124     Source Type: Journal    
DOI: 10.5731/pdajpst.2013.00899     Document Type: Article

References (32)

1. Gupta, M. K.; Vanwert, A.; Bonger, R. H. Formation of physically stable amorphous drugs by milling with Neusilin. J. Pharm. Sci. 2003, 92 (3), 536-551.
2. Corrigan, O. I. Thermal analysis of spray dried products. Thermochimica Acta 1995, 248, 245-258.
3. Gajare, P.; Patil, C.; Kalyane, N.; Pore, Y. Effect of hydrophilic polymers on pioglitazone complexation with hydrorypropyl-β-cyclodextrin. Digest Journal of Nanomaterials and Biostructures 2009, 4 (4), 891- 897.
4. Prajapati, S. T.; Gohel, M. C.; Patel, L. D. Studies to enhance dissolution properties of carbamazepine. Indian J. Pharm. Sci. 2007, 69 (3), 427-430.
5. Ambike, A.; Mahadik, K.; Paradkar, A. Spraydried amorphous solid dispersions of Simvastatin, a low Tg drug: in vitro and in vivo evaluations. Pharm. Res. 2005, 22 (6), 990-998.
6. Chauhan, B.; Shimpi, S.; Paradkar, A. Preparation and characterization of etoricoxib solid dispersion using lipid carriers by spray drying technique. AAPS PharmSciTech 2005, 6 (3), E405-E409.
7. Hu, J.; Rogers, T. L.; Brown, J.; Young, T.; Johnstan, K. P.; Williams, R. O. Improvement of dissolution rates of poorly water soluble APIs using novel spray freezing into liquid technology. Pharm. Res. 2002, 19 (9), 1278-1284.
8. Fini, A.; Roderguez, C.; Cavallari, C.; Albertini, B.; Passerini, N. Ultrasound compacted and spray congealed indomethacin/polyethylene glycol systems. Int. J. Pharm. 2002, 247 (1-2), 11-22.
9. Brietenbach, J.; Berndl, G.; Neumann, J.; Rosenber, J.; Simon, O.; Zeidler, J. Solid dispersion by integrated melt extrusion systems. Proc. Int. Symp. Control Rel. Bioact. Mater. 1998, 25, 804-805.
10. Damian, F.; Blaton, N.; Naesens, L.; Balzarini, J.; Kinget, R.; Augustijns, P.; Van den Mooter, G. Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur. J. Pharm. Sci. 2000, 10 (4), 311-322.
11. Abdul-Fattah, A. M.; Bhargava, H. N. Preparation and in vitro evaluation of solid dispersions of halofantrine. Int. J. Pharm. 2002, 235 (1-2), 17-33.
12. Sethia, S.; Squillante, E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int. J. Pharm. 2004, 272 (1-2), 1-10.
13. Doshi, D. H.; Ravis, W. R.; Betageri, G. V. Carbamazepine and polyethylene glycol solid dispersions: preparation, in vitro dissolution, and characterization. Drug Dev. Ind. Pharm. 1997, 23 (12), 1167-1176.
14. Kazuto, O.; Masatoshi, M.; Rinta, I.; Mituru, Y.; Norio, O.; Tasuku, N. Dissolution mechanism and rate of solid dispersion particles of nilvadipine with hydroxypropyl methylcellulose. Int. J. Pharm. 1997, 159 (1), 85-93.
15. Hirasawa, N.; Ishise, S.; Miyata, H.; Danjo, K. An attempt to stabilize nilvadipine solid dispersion by the use of ternary systems. Drug Dev. Ind. Pharm. 2003, 29 (9), 997-1004.
16. Karavas, E.; Ktistis, G.; Xenakis, A.; Georgarakis, E. Miscibility behavior and formation mechanism of stabilized felodipine-polyvinylpyrrolidone amorphous solid dispersions. Drug Dev. Ind. Pharm. 2005, 31 (6), 473- 89.
17. Hirasawa, N.; Danij, K.; Haruna, M.; Otsuka, A. Physicochemical characterization and drug release studies of naproxen solid dispersion using lactose as a carrier. Chem. Pharm. Bull. 1998, 46 (6), 1027-1030.
18. Rawat, S.; Jain, S. K. Rofecoxib-beta-cyclodextrin inclusion complex for solubility enhancement. Pharmazie 2003, 58 (9), 639 - 641.
19. LaMonte, M. J.; Blair, S. N.; Church, T. S. Physical activity and diabetes prevention. J. Appl. Physiol. 2005, 99 (3), 1205-1213.
20. Hancock, B. C.; Zografi, G. Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 1997, 86 (1), 1-12.
21. Lian, Y. Amorphous pharmaceutical solids: preparation, characterization and stabilization. Adv. Drug Del. Rev. 2001, 48 (1), 27- 42.
22. Paradkar, A.; Ambike, A.; Jadhav, B. K.; Mahadik, K. R. Characterization of curcumin-PVP solid dispersion obtained by spray drying. Int. J. Pharm. 2004, 271 (1-2), 281-286.
23. Ambike, A. A.; Mahadik, K. R.; Paradkar, A. Stability study of amorphous valdecoxib. Int. J. Pharm. 2004, 282 (1-2), 151-162.
24. Ketkar, A. R.; Patil, V. B.; Paradkar, A. R. Computer Aided Exploratory Data Analysis Model Fitting for Dissolution Kinetics: 4th International Symposium on Advances in Technology and Business Potential of New Drug Delivery System. Controlled Release Society Indian Chapter, Mumbai, India, 2002, p 62.
25. Badole, S. L.; Bodhankar, S. L. Concomitant administration of petroleum ether extract of the stem bank of Pongamia pinnata (L.) Pierre with synthetic oral hypoglycemic drugs in alloxaninduced diabetic mice. Eur. J. Integrative Medicine 2009, 1 (2), 73-79.
26. Selvam, P. Evaluation of antidiabetic activity of a polyherbal formulation in alloxan induced diabetic rats. Int. J. Pham. Sci. Res. 2010, 1 (9), 82- 87.
27. Seedher, N.; Kanojia, M. Co-solvent solubilization of some poorly-soluble antidiabetic drugs. Pharm. Dev. Technol. 2009, 14 (2), 185-192.
28. Bhole, P. G.; Patil, V. R. Enhancement of water solubility of felodipine by preparing solid dispersion using poly-ethylene glycol 6000 and poly-vinyl alcohol. Asian J Pharm. 2009, 3 (3), 240-244.
29. Karataş, A.; Yüksel, N.; Baykara, T. Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol. Farmaco 2005, 60 (9), 777-782.
30. Taylor, L. S.; Zografi, G. Spectroscopic characterization of interaction between PVP and indomethacin in amorphous molecular dispersions. Pharm. Res. 1997, 14 (12), 1691-1698.
31. Won, D. H.; Kim, M. S.; Lee, S.; Park, J. S.; Hwang, S. J. Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process. Int. J. Pharm. 2005, 301 (1-2), 199-208.
32. Patel, R. P.; Patel, M. M. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30. Pharm. Dev. Technol. 2007, 12 (1), 21-33.